{"id":84449,"date":"2026-10-27T15:54:10","date_gmt":"2026-10-27T04:54:10","guid":{"rendered":"https:\/\/riskinfo.com.au\/news\/?p=84449"},"modified":"2026-10-27T15:54:10","modified_gmt":"2026-10-27T04:54:10","slug":"challenger-declines-tal-takeover-offer","status":"publish","type":"post","link":"https:\/\/riskinfo.com.au\/news\/2026\/10\/27\/challenger-declines-tal-takeover-offer\/","title":{"rendered":"Challenger Declines TAL Takeover Offer"},"content":{"rendered":"<p>Challenger says the non-binding and conditional indicative offer from TAL to acquire the remaining ordinary shares in Challenger it does not already own, is not at a level it could recommend to shareholders.<\/p>\n<p>Challenger says in a statement that its Board \u201c\u2026has met and carefully considered the offer, having regard to Challenger&#8217;s value and prospects. The Board has concluded the offer is not at a level it could recommend to shareholders.\u201d<\/p>\n<p>TAL is a subsidiary of Daichi Life Group, and Challenger says it \u201c\u2026highly values TAL Daiichi Life Australia as its largest shareholder and a commercial partner, and the Board intends to engage with TDA to see whether a proposal can be reached that the Board could recommend.\u201d<\/p>\n<p>It says: \u201cThere is no certainty that the proposal will result in a binding offer or that any transaction will eventuate.\u201d<\/p>\n<p>The indicative offer was by way of a scheme of arrangement at a price of $11.80 per share (see: <a href=\"https:\/\/riskinfo.com.au\/news\/2026\/10\/20\/tal-proposes-full-challenger-acquisition\/\" target=\"_blank\" rel=\"noopener\">TAL Proposes Full Challenger Acquisition<\/a>).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Challenger says the non-binding and conditional indicative offer from TAL to acquire the remaining ordinary shares in Challenger it does not already own, is not at a level it could recommend to shareholders. Challenger says in a statement that its Board \u201c\u2026has met and carefully considered the offer, having regard to Challenger&#8217;s value and prospects. [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":84452,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,7734],"tags":[],"class_list":["post-84449","post","type-post","status-publish","format-standard","has-post-thumbnail","category-company-news","category-featured"],"_links":{"self":[{"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/posts\/84449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/comments?post=84449"}],"version-history":[{"count":5,"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/posts\/84449\/revisions"}],"predecessor-version":[{"id":84456,"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/posts\/84449\/revisions\/84456"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/media\/84452"}],"wp:attachment":[{"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/media?parent=84449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/categories?post=84449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/riskinfo.com.au\/news\/wp-json\/wp\/v2\/tags?post=84449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}